sdLDL-C与2型糖尿病合并高血压疾病的研究进展
Research Progress on sdLDL-C and Type 2 Diabetes Combined with Hypertension Disease
DOI: 10.12677/acm.2025.1572150, PDF,   
作者: 付阳阳：北华大学临床医学院，吉林 吉林；毛 骞*：北华大学附属医院内分泌科，吉林 吉林
关键词: 小而密低密度脂蛋白；2型糖尿病；高血压病；Small and Dense Low-Density Lipoprotein； Type 2 Diabetes Mellitus； Hypertension
摘要: 临床观察表明，同时罹患2型糖尿病(T2DM)和高血压的个体普遍存在脂质代谢紊乱及血管内皮功能障碍，进一步可进展为动脉粥样硬化，小而密低密度脂蛋白(sdLDL-C)亚型在预测动脉粥样硬化进程和评估心血管事件风险方面具有重要的临床价值。因此，加强对这类患者sdLDL-C水平的监测，有助于更早实施干预措施，实现早期预防和治疗。
Abstract: Clinical observations indicate that lipid metabolism disorders and vascular endothelial dysfunction are prevalent in individuals with type 2 diabetes mellitus (T2DM) and hypertension, which can further progress to atherosclerosis. Small and dense low-density lipoprotein (sdLDL-C) subtypes have important clinical value in predicting the progression of atherosclerosis and assessing the risk of cardiovascular events. Therefore, strengthening the monitoring of sdLDL-C levels in such patients will help to implement interventions earlier and achieve early prevention and treatment.
文章引用：付阳阳, 毛骞. sdLDL-C与2型糖尿病合并高血压疾病的研究进展[J]. 临床医学进展, 2025, 15(7): 1474-1481. https://doi.org/10.12677/acm.2025.1572150

参考文献

[1] Hirayama, S. and Miida, T. (2012) Small Dense LDL: An Emerging Risk Factor for Cardiovascular Disease. Clinica Chimica Acta, 414, 215-224. [Google Scholar] [CrossRef] [PubMed]
[2] Ivanova, E.A., Myasoedova, V.A., Melnichenko, A.A., Grechko, A.V. and Orekhov, A.N. (2017) Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 1273042. [Google Scholar] [CrossRef] [PubMed]
[3] Masuda, D., Miyata, Y., Matsui, S. and Yamashita, S. (2020) Omega-3 Fatty Acid Ethyl Esters Improve Low-Density Lipoprotein Subclasses without Increasing Low-Density Lipoprotein-Cholesterol Levels: A Phase 4, Randomized Study. Atherosclerosis, 292, 163-170. [Google Scholar] [CrossRef] [PubMed]
[4] Berneis, K.K. and Krauss, R.M. (2002) Metabolic Origins and Clinical Significance of LDL Heterogeneity. Journal of Lipid Research, 43, 1363-1379. [Google Scholar] [CrossRef] [PubMed]
[5] Jin, X., Yang, S., Lu, J. and Wu, M. (2022) Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies. Frontiers in Cardiovascular Medicine, 8, Article ID: 804214. [Google Scholar] [CrossRef] [PubMed]
[6] Zheng, C., Khoo, C., Furtado, J. and Sacks, F.M. (2010) Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype. Circulation, 121, 1722-1734. [Google Scholar] [CrossRef] [PubMed]
[7] Biadgo, B., Abebe, S.M., Baynes, H.W., Yesuf, M., Alemu, A. and Abebe, M. (2017) Correlation between Serum Lipid Profile with Anthropometric and Clinical Variables in Patients with Type 2 Diabetes Mellitus. Ethiopian Journal of Health Sciences, 27, 215-226. [Google Scholar] [CrossRef] [PubMed]
[8] Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N.E., Ahfeldt, T., Sachs, K.V., et al. (2010) From Noncoding Variant to Phenotype via SORT1 at the 1p13 Cholesterol Locus. Nature, 466, 714-719. [Google Scholar] [CrossRef] [PubMed]
[9] Van Craeyveld, E., Gordts, S.C., Nefyodova, E., Jacobs, F. and De Geest, B. (2011) Regression and Stabilization of Advanced Murine Atherosclerotic Lesions: A Comparison of LDL Lowering and HDL Raising Gene Transfer Strategies. Journal of Molecular Medicine, 89, 555-567. [Google Scholar] [CrossRef] [PubMed]
[10] Hoogeveen, R.C., Gaubatz, J.W., Sun, W., Dodge, R.C., Crosby, J.R., Jiang, J., et al. (2014) Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1069-1077. [Google Scholar] [CrossRef] [PubMed]
[11] Tsuzaki, K., Kotani, K., Sano, Y., Fujiwara, S., Takahashi, K. and Sakane, N. (2010) The Association of the Clock 3111 T/C SNP with Lipids and Lipoproteins Including Small Dense Low-Density Lipoprotein: Results from the Mima Study. BMC Medical Genetics, 11, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
[12] 张扬, 梁伟. 小而密低密度脂蛋白胆固醇与老年动脉粥样硬化性疾病关系的研究进展[J]. 中西医结合心脑血管病杂志, 2022, 20(20): 3721-3723.
[13] Siewert, S., Gonzalez, I.I., Lucero, R.O. and Ojeda, M.S. (2014) Association of Cholesteryl Ester Transfer Protein Genotypes with Paraoxonase-1 Activity, Lipid Profile and Oxidative Stress in Type 2 Diabetes Mellitus: A Study in San Luis, Argentina. Journal of Diabetes Investigation, 6, 67-77. [Google Scholar] [CrossRef] [PubMed]
[14] Berneis, K., Jeanneret, C., Muser, J., Felix, B. and Miserez, A.R. (2005) Low-Density Lipoprotein Size and Subclasses Are Markers of Clinically Apparent and Non-Apparent Atherosclerosis in Type 2 Diabetes. Metabolism, 54, 227-234. [Google Scholar] [CrossRef] [PubMed]
[15] Higashioka, M., Sakata, S., Honda, T., Hata, J., Yoshida, D., Hirakawa, Y., et al. (2020) Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community. Journal of Atherosclerosis and Thrombosis, 27, 669-682. [Google Scholar] [CrossRef] [PubMed]
[16] 陈桂金, 万友利. 小而密低密度脂蛋白胆固醇与冠心病的相关性分析[J]. 国际检验医学杂志, 2021, 42(16): 1925-1928.
[17] Wu, D., Yang, Q., Su, B., Hao, J., Ma, H., Yuan, W., et al. (2021) Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development. Frontiers in Cardiovascular Medicine, 8, Article ID: 619386. [Google Scholar] [CrossRef] [PubMed]
[18] 陈芊, 谢菲, 李庆, 等. 2型糖尿病患者血浆致动脉硬化指数相关因素的研究[J]. 现代实用医学, 2018, 30(2): 211-213.
[19] Kim, S.H., Cho, Y.K., Kim, Y., Jung, C.H., Lee, W.J., Park, J., et al. (2022) Association of the Atherogenic Index of Plasma with Cardiovascular Risk Beyond the Traditional Risk Factors: A Nationwide Population-Based Cohort Study. Cardiovascular Diabetology, 21, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[20] Ikezaki, H., Furusyo, N., Yokota, Y., Ai, M., Asztalos, B.F., Murata, M., et al. (2020) Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression. Journal of Atherosclerosis and Thrombosis, 27, 1108-1122. [Google Scholar] [CrossRef] [PubMed]
[21] Hirano, T., Kodera, R., Hirashima, T., Suzuki, N., Aoki, E., Hosoya, M., et al. (2022) Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol. Journal of Atherosclerosis and Thrombosis, 29, 762-774. [Google Scholar] [CrossRef] [PubMed]
[22] 赵丽娜, 石光煜, 郭喆, 等. LDL-C水平正常的老年人颈动脉硬化斑块形成及其稳定分型与TG/HDL-C比值、sdLDL-C指标的相关性[J]. 海军军医大学学报, 2023, 44(8): 994-1000.
[23] 王德生. 老年高血压人群中血脂、血尿酸水平的检验结果分析[J]. 中国医药指南, 2016, 14(29): 109-110.
[24] 潘逸茹, 喻红之, 曹悦, 等. 老年人群血清小而密低密度脂蛋白胆固醇分布及其与高血压的相关性[J]. 老年医学与保健, 2018, 24(4): 367-371.
[25] Vekic, J., Zeljkovic, A., Stefanovic, A., Jelic-Ivanovic, Z. and Spasojevic-Kalimanovska, V. (2019) Obesity and Dyslipidemia. Metabolism, 92, 71-81. [Google Scholar] [CrossRef] [PubMed]
[26] Hirano, T. (2018) Pathophysiology of Diabetic Dyslipidemia. Journal of Atherosclerosis and Thrombosis, 25, 771-782. [Google Scholar] [CrossRef] [PubMed]
[27] Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article 107843. [Google Scholar] [CrossRef] [PubMed]
[28] Izzo, R., de Simone, G., Chinali, M., Iaccarino, G., Trimarco, V., Rozza, F., et al. (2009) Insufficient Control of Blood Pressure and Incident Diabetes. Diabetes Care, 32, 845-850. [Google Scholar] [CrossRef] [PubMed]
[29] Sowers, J.R. (2013) Diabetes Mellitus and Vascular Disease. Hypertension, 61, 943-947. [Google Scholar] [CrossRef] [PubMed]
[30] Tatsumi, Y. and Ohkubo, T. (2017) Hypertension with Diabetes Mellitus: Significance from an Epidemiological Perspective for Japanese. Hypertension Research, 40, 795-806. [Google Scholar] [CrossRef] [PubMed]
[31] Wei, G.S., Coady, S.A., Goff, D.C., Brancati, F.L., Levy, D., Selvin, E., et al. (2011) Blood Pressure and the Risk of Developing Diabetes in African Americans and Whites: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care, 34, 873-879. [Google Scholar] [CrossRef] [PubMed]
[32] Fève, B. and Bastard, J. (2009) The Role of Interleukins in Insulin Resistance and Type 2 Diabetes Mellitus. Nature Reviews Endocrinology, 5, 305-311. [Google Scholar] [CrossRef] [PubMed]
[33] Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N. and Manson, J.E. (2004) Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women. Diabetes, 53, 693-700. [Google Scholar] [CrossRef] [PubMed]
[34] 陈涛, 涂梅, 黄建青, 等. 福建非沿海地区初诊2型糖尿病合并原发性高血压老年患者血清尿酸水平与胰岛素抵抗的相关性[J]. 中华高血压杂志, 2021, 29(1): 62-67.
[35] Jia, G. and Sowers, J.R. (2021) Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension, 78, 1197-1205. [Google Scholar] [CrossRef] [PubMed]
[36] 苏俊, 许宏, 杨军强. 2型糖尿病合并高血压患者血脂、血糖代谢情况及其与高血压病程的关系[J]. 贵州医药, 2019, 43(10): 1564-1565.
[37] 郑帅印, 李砥, 李丽丹, 等. 高血压合并2型糖尿病线图预测模型建立[J]. 中国预防医学杂志, 2022, 23(2): 121-127.
[38] 石红梅, 邢丽丽, 汪静. 北京市东城区糖尿病患者治疗和控制现状及其影响因素分析[J]. 中国公共卫生, 2021, 37(7): 1161-1165.
[39] Santos, H.O., Earnest, C.P., Tinsley, G.M., Izidoro, L.F.M. and Macedo, R.C.O. (2020) Small Dense Low-Density Lipoprotein-Cholesterol (sdLDL-C): Analysis, Effects on Cardiovascular Endpoints and Dietary Strategies. Progress in Cardiovascular Diseases, 63, 503-509. [Google Scholar] [CrossRef] [PubMed]
[40] 木那瓦尔·克热木, 迪拉热·阿迪, 魏娴, 等. 小而密低密度脂蛋白与心血管疾病相关性的研究进展[J]. 中国心血管杂志, 2023, 28(6): 583-587.

为你推荐